Dr Reddy's Laboratories earmarks capex of around Rs 1,500 crore for FY23

07 Nov 2022 Evaluate

Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses. The company also plans to utilise the capital for adding capacities to existing plants, firm up R&D activities and further invest in digitisation projects.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1171.50 -4.05 (-0.34%)
19-Jan-2026 12:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1680.25
Dr. Reddys Lab 1171.50
Cipla 1390.90
Zydus Lifesciences 865.00
Lupin 2187.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×